Bio-Techne: Attractive Markets And A Good Moat, But Valuation Is Seldom A Bargain

Core Insights - The article discusses the challenges faced by Bio-Techne (NASDAQ: TECH) since the peak of life sciences and bioprocessing R&D and capital expenditures [1] Company Analysis - Bio-Techne has experienced a downturn in its performance, reflecting broader trends in the life sciences sector [1] Industry Overview - The life sciences and bioprocessing industry has seen a decline in R&D and capital expenditures since their peak, impacting companies like Bio-Techne [1]